J. Kreuter

J. Kreuter, A. Berthold, K. Cremer, 1998, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

How subtle differences in polymer molecular weight affect doxorubicin-loaded PLGA nanoparticles degradation and drug release

M. Gorshkova, J. Kreuter, S. Gelperina, 2020, Journal of microencapsulation.

Cytotoxic effects of treosulfan and busulfan against leukemic cells of pediatric patients

S. Zimmermann, T. Klingebiel, R. Schubert, 2008, Cancer Chemotherapy and Pharmacology.

Methylmethacrylate sulfopropylmethacrylate copolymer nanoparticles for drug delivery: Part III: Evaluation as drug delivery system for ophthalmic applications

K. Langer, J. Kreuter, E. Mutschler, 1997 .

Transdermal delivery of the tetrapeptide hisetal (melanotropin (6–9)). I. Effect of various penetration enhancers: in vitro study across hairless mouse skin

J. Kreuter, J. H. Rytting, A. Ruland, 1994 .

Drug delivery and targeting to the CNS - Preface

D. Begley, J. Kreuter, 2002 .

Kinetics of transport of doxorubicin bound to nanoparticles across the blood-brain barrier.

D. Begley, J. Kreuter, S. Gelperina, 2011, Journal of controlled release : official journal of the Controlled Release Society.

Influence of the surfactant concentration on the body distribution of nanoparticles.

R. Löbenberg, J. Kreuter, L Araujo, 1999, Journal of drug targeting.

Desolvation process and surface characterisation of protein nanoparticles.

K. Langer, J. Kreuter, C. Weber, 2000, International journal of pharmaceutics.

Influence of various penetration enhancers on the in vitro permeation of amino acids across hairless mouse skin

J. Kreuter, A. Ruland, 1992 .

A γ-scintigraphic evaluation of microparticulate ophthalmic delivery systems: liposomes and nanoparticles

Clive G. Wilson, J. Hadgraft, J. Kreuter, 1987 .

Gelatin nanoparticles by two step desolvation--a new preparation method, surface modifications and cell uptake.

J. Kreuter, K. Langer, J. Kreuter, 2000, Journal of microencapsulation.

Influence of crosslinking on the acid stability and physicochemical properties of chitosan microspheres

J. Kreuter, A. Berthold, K. Cremer, 1996 .

Simple and efficient method for the detection of diethylenetriaminepentaacetic acid.

M. Michaelis, J. Vogel, J. Kreuter, 1999, Journal of chromatography. B, Biomedical sciences and applications.

Improved body distribution of 14C-labelled AZT bound to nanoparticles in rats determined by radioluminography.

J Maas, R. Löbenberg, J. Kreuter, 1998, Journal of drug targeting.

Covalent Linkage of Apolipoprotein E to Albumin Nanoparticles Strongly Enhances Drug Transport into the Brain

M. Michaelis, K. Langer, R. Alyautdin, 2006, Journal of Pharmacology and Experimental Therapeutics.

Contact angles of surfactants with a potential to alter the body distribution of colloidal drug carriers on poly(methyl methacrylate) surfaces

J. Kreuter, S. Tröster, 1988 .

Discovery of substituted N-phenylbenzenesulphonamides as a novel class of non-nucleoside hepatitis C virus polymerase inhibitors.

B. Riedl, T. Marquardt, H. Zimmermann, 2012, Antiviral research.

Comparison of 24 different adjuvants for inactivated HIV-2 split whole virus as antigen in mice. Induction of titres of binding antibodies and toxicity of the formulations.

J. Löwer, D. Crommelin, G. Kersten, 1995, Vaccine.

Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80-coated polybutylcyanoacrylate nanoparticles: an in situ brain perfusion study.

D. A. Kharkevich, D. Begley, R. Alyautdin, 1998, Journal of microencapsulation.

Preparation, characterisation and maintenance of drug efficacy of doxorubicin-loaded human serum albumin (HSA) nanoparticles.

M. Michaelis, J. Cinatl, J. Kreuter, 2007, International journal of pharmaceutics.

Methylmethacrylate sulfopropylmethacrylate copolymer nanoparticles for drug delivery: Part II: arecaidine propargyl ester and pilocarpine loading and in vitro release

K. Langer, J. Kreuter, E. Mutschler, 1997 .

Characterisation of polybutylcyanoarylate nanoparticles: I. Quantification of PCBA polymer and dextrans

K. Langer, J. Kreuter, A. Zimmer, 1994 .

Influence of the type of surfactant on the analgesic effects induced by the peptide dalargin after its delivery across the blood–brain barrier using surfactant-coated nanoparticles

R. Alyautdin, Petrov Ve, J. Kreuter, 1997 .

Preparation of avidin-labeled protein nanoparticles as carriers for biotinylated peptide nucleic acid.

H von Briesen, H. von Briesen, K. Langer, 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Quantitative colorimetric and gas chromatographic determination of arecaidine propargyl ester.

J. Kreuter, E. Mutschler, U. Moser, 1997, Journal of chromatography. B, Biomedical sciences and applications.

[Drug delivery to the brain with nanoparticles].

J. Kreuter, D. Kharkevich, R. N. Aliautdin, 2003, Eksperimental'naia i klinicheskaia farmakologiia.

Release of the fluorescent marker Prodan® from poly(D,L-lactic acid) nanoparticles coated with albumin or polyvinyl alcohol in model digestive fluids (USP XXII)

D. Bazile, G. Spenlehauer, M. Veillard, 1997 .

A phase I study of safety and pharmacokinetics of NanoBB-1-Dox in patients with advanced solid tumors.

J. Kreuter, S. Gelperina, P. Krivorotko, 2017 .

Nanoparticles as Drug Delivery Systems for the Brain

J. Kreuter, 2006 .

Kinetics of transport of doxorubicin bound to nanoparticles across the blood-brain barrier.

D. Begley, J. Kreuter, S. Gelperina, 2011, Journal of controlled release : official journal of the Controlled Release Society.

[Transport of the hexapeptide dalargin across the hemato-encephalic barrier into the brain using polymer nanoparticles].

D. A. Kharkevich, J. Kreuter, V. Petrov, 1996, Eksperimental'naia i klinicheskaia farmakologiia.